AdaptHealth Corp. (NASDAQ:AHCO) Shares Acquired by Trexquant Investment LP

Trexquant Investment LP lifted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO – Get Rating) by 105.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 71,293 shares of the company’s stock after purchasing an additional 36,590 shares during the quarter. Trexquant Investment LP owned about 0.05% of AdaptHealth worth $1,339,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Resource Consulting Group Inc. acquired a new position in shares of AdaptHealth during the 3rd quarter worth $2,646,000. TCW Group Inc. acquired a new position in shares of AdaptHealth during the 3rd quarter worth $503,000. Macquarie Group Ltd. acquired a new position in shares of AdaptHealth during the 3rd quarter worth $3,483,000. Kennedy Capital Management Inc. grew its stake in shares of AdaptHealth by 10.6% during the 2nd quarter. Kennedy Capital Management Inc. now owns 629,106 shares of the company’s stock worth $11,349,000 after purchasing an additional 60,371 shares during the period. Finally, Palisade Capital Management LLC NJ grew its stake in shares of AdaptHealth by 9.0% during the 3rd quarter. Palisade Capital Management LLC NJ now owns 1,232,999 shares of the company’s stock worth $23,156,000 after purchasing an additional 101,571 shares during the period. 86.33% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on AHCO shares. Robert W. Baird lowered their price target on shares of AdaptHealth from $31.00 to $23.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 1st. SVB Securities lowered their price objective on shares of AdaptHealth from $30.00 to $23.00 in a research note on Wednesday, March 1st. Finally, Truist Financial lowered their price objective on shares of AdaptHealth from $28.00 to $20.00 in a research note on Wednesday, March 1st. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of $25.33.

AdaptHealth Price Performance

Shares of NASDAQ AHCO opened at $13.80 on Monday. The stock has a market cap of $1.86 billion, a price-to-earnings ratio of 53.08, a PEG ratio of 0.61 and a beta of 0.71. The company has a current ratio of 1.28, a quick ratio of 1.00 and a debt-to-equity ratio of 1.00. The company’s 50-day moving average price is $20.03 and its 200 day moving average price is $20.37. AdaptHealth Corp. has a 52 week low of $11.40 and a 52 week high of $27.48.

Insider Buying and Selling at AdaptHealth

In other AdaptHealth news, major shareholder Everest Hill Group Inc. sold 4,789 shares of the company’s stock in a transaction dated Wednesday, January 18th. The shares were sold at an average price of $22.00, for a total value of $105,358.00. Following the transaction, the insider now directly owns 13,445,008 shares in the company, valued at approximately $295,790,176. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last ninety days, insiders have sold 1,140,000 shares of company stock worth $23,269,789. Corporate insiders own 17.30% of the company’s stock.

About AdaptHealth

(Get Rating)

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs.